Page 99 - AN-2-3
P. 99

Advanced Neurology                                                 eGFR and serum neurofilament light chain




            Table 3. Multivariate analysis of the association between eGFR and sNfL
             Variables            Model 1                       Model 2                       Model 3
                         β (95% CI [upper   P‑value     β (95% CI [upper   P‑value   β (95% CI [upper   P‑value
                         limit, lower limit])           limit, lower limit])         limit, lower limit])
            eGFR        −0.22 (−0.34, −0.10)  0.01      −0.2 (−0.31, −0.10)  0.01    −0.2 (−0.30, −0.10)  <0.01
            eGFR
             Q1             1.00 (ref)                     1.00 (ref)                   1.00 (ref)
             Q2         −6.06 (−11.20, −0.91)  0.03    −4.81 (−9.31, −0.30)  0.04    −4.8 (−9.21, −0.39)  0.03
             Q3         −7.22 (−12.82, −1.61)  0.02    −7.05 (−12.33, −1.77)  0.01  −7.28 (−12.63, −1.92)  0.01
             Q4         −5.8 (−10.60, −1.01)  0.03     −5.63 (−9.98, −1.29)  0.01   −5.78 (−10.24, −1.31)  0.01
            Notes: Q1 (1.86–82.82), Q2 (82.82–98.39), Q3 (98.39–111.39), Q4 (111.39–159.93). Model 1: Adjust age + sex + education + marital; Model 2: Adjust
            model 1 + drink+smoke + CKD + HF + MI + MetS + DM; Model 3: Adjust model 2 + hyperlipidemia + hypertension + stroke. CI: Confidence interval;
            eGFR: Estimated glomerular filtration rate; sNfL: Serum neurofilament light chain.
            Table 4. Threshold effect analysis of eGFR on sNfL by the two‑piecewise linear regression

             Variable                                β (95% CI [upper limit, lower limit])        P‑value
            Fitting by standard linear model               −0.20 (−0.20, −0.10)                    <0.01
            Fitting by two-piecewise linear model
            Inflection point                                    59.9
             eGFR <59.9                                    −1.00 (−1.30, −0.80)                    <0.01
             eGFR >59.9                                    −0.10 (−0.10,0.00)                      0.01
            Log-likelihood ratio                               <0.001
            Abbreviations: CI: Confidence interval; eGFR: Estimated glomerular filtration rate.

                                                               mechanism is that hypertension could lead to vascular
                                                               damage and inflammation, contributing to neuronal injury
                                                               and increased sNfL levels in individuals with decreased
                                                               eGFR. Neuronal damage can result in an elevation of sNfL
                                                               levels [20,21] . Hypertension can increase the expression of
                                                               adhesion factors in brain endothelial cells, leading to platelet
                                                               deposition. This, in turn, activates glial cells and NF-κB signal
                                                               transduction,  ultimately  resulting  in  neuronal  damage .
                                                                                                           [22]
                                                               Furthermore, sustained intracranial hypertension can cause
                                                               cerebral perfusion damage and neuronal injury, resulting in
                                                               secondary brain injury . It has been found that hypertension
                                                                                [23]
                                                               is associated with sNfL levels, and previous studies have
                                                               reported a correlation between sNfL levels in cerebrospinal
                                                               fluid and idiopathic intracranial hypertension [24,25] .
                                                                 In previous studies, age has been identified as an
                                                               important factor affecting sNfL levels, with a more
                                                               significant impact observed in participants aged 60 or
            Figure 1. Association of estimated glomerular filtration rate with serum   older . Our research findings align with this observation.
                                                                   [26]
            neurofilament light chain levels.                  In  our  subgroup  analysis,  when  adjusting  for  other
            Abbreviations: eGFR: Estimated glomerular filtration rate; sNfL: Serum
            neurofilament light chain.                         covariates except for age, we observed a higher influence
                                                               ratio of participants aged 60  years or older (β  = −0.36,
            Subsequent research has also demonstrated that individuals   P  = 0.07) on the relationship between eGFR and sNfL
            with higher blood pressure experience a faster annual decline   compared to participants younger than 60 years (β = −0.17,
            in eGFR . These findings suggest that hypertension may   P  < 0.01), although the  P-value for the former was not
                   [19]
            modify  the  effect  of  eGFR  on  sNfL  levels.  One  plausible   statistically significant.

            Volume 2 Issue 3 (2023)                         6                         https://doi.org/10.36922/an.1394
   94   95   96   97   98   99   100   101   102   103   104